These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 12271419)

  • 1. Myocardial distribution of (18)F-FDG and (99m)Tc-sestamibi on dual-isotope simultaneous acquisition SPET compared with PET.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Takekoshi N; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1357-64. PubMed ID: 12271419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
    Matsunari I; Kanayama S; Yoneyama T; Matsudaira M; Nakajima K; Taki J; Nekolla SG; Tonami N; Hisada K
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):195-202. PubMed ID: 15449050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
    Slart RH; Bax JJ; van Veldhuisen DJ; van der Wall EE; Irwan R; Sluiter WJ; Dierckx RA; de Boer J; Jager PL
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):716-23. PubMed ID: 16523309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
    Slart RH; Bax JJ; de Boer J; Willemsen AT; Mook PH; Oudkerk M; van der Wall EE; van Veldhuisen DJ; Jager PL
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):972-9. PubMed ID: 15824927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
    De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
    Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gated 99mTc-tetrofosmin and 18F-FDG studies: a comparison of single-acquisition and separate-acquisition protocols.
    Pagnanelli RA; Hanson MW; Turkington T; Coleman RE; Borges-Neto S
    J Nucl Med Technol; 2002 Dec; 30(4):175-8. PubMed ID: 12446750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.
    Schaefer WM; Nowak B; Kaiser HJ; Koch KC; Block S; vom Dahl J; Buell U
    J Nucl Med; 2003 Jan; 44(1):33-9. PubMed ID: 12515874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
    Wang L; Wei HX; Yang MF; Guo J; Wang JF; Fang W; Wang YT
    Ann Nucl Med; 2013 May; 27(4):325-34. PubMed ID: 23371445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of myocardial blood flow and myocardial flow reserve by 99mTc-sestamibi imaging: comparison with the results of [15O]H2O PET.
    Ito Y; Katoh C; Noriyasu K; Kuge Y; Furuyama H; Morita K; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):281-7. PubMed ID: 12552347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial viability using F-18 fluorodeoxyglucose/Tc-99m sestamibi dual-isotope simultaneous acquisition SPECT: comparison with Tl-201 stress-reinjection SPECT.
    Wu YW; Huang PJ; Lee CM; Ho YL; Lin LC; Wang TD; Wang SS; Chen TH; Yen RF
    J Nucl Cardiol; 2005; 12(4):451-9. PubMed ID: 16084434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
    Martin WH; Jones RC; Delbeke D; Sandler MP
    Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose dobutamine stress gated SPET for identification of viable myocardium: comparison with stress-rest perfusion SPET and PET.
    Yoshinaga K; Katoh C; Noriyasu K; Yamada S; Ito Y; Kuge Y; Kawai Y; Kohya T; Kitabatake A; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):882-90. PubMed ID: 12111128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Head to head comparison of dobutamine alone and combined with nitrate stress echocardiography and 99mTc-MIBI/18FDG myocardial SPECT image for diagnosis of viable myocardium in patients with severe left ventricular dysfunction].
    Yang YJ; Yang WX; Shi RF; Hu FH; You SJ; Tian YQ; He ZX; Wang YW; Ye L; Chen JL; Gao RL; Chen ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):323-7. PubMed ID: 15932661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
    Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
    J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of myocardial viability with (99m)Tc-sestamibi -gated SPET images in patients undergoing percutaneous transluminar coronary angioplasty.
    Tzonevska A; Tzvetkov K; Dimitrova M; Piperkova E
    Hell J Nucl Med; 2005; 8(1):48-53. PubMed ID: 15886754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both.
    Arrighi JA; Ng CK; Dey HM; Wackers FJ; Soufer R
    Am J Cardiol; 1997 Oct; 80(8):1007-13. PubMed ID: 9352969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction.
    Nowak B; Zimny M; Schwarz ER; Kaiser HJ; Schaefer W; Reinartz P; vom Dahl J; Buell U
    Eur J Nucl Med; 2000 Oct; 27(10):1501-8. PubMed ID: 11083539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.